Live Vital Review
Best for: shoppers who want low-cost, physician-led compounded GLP-1 with peptide and hormone options
Live Vital is a physician-led telehealth practice founded by Dr. Patrick Taylor, MD, offering compounded GLP-1 weight loss — semaglutide from $99/mo and tirzepatide from $183/mo, billed as 3-month programs — alongside peptide and hormone therapy. Every plan is doctor-prescribed, filled by a licensed US pharmacy, and shipped to your door, with unlimited care-team messaging and no lock-in. Fully telehealth in all 50 states.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Live Vital is one of the most affordable GLP-1 options on the market.
How we scored Live Vital
Each dimension is scored algorithmically from Live Vital’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
9.0/10At $99/mo, Live Vital runs about 41% below the $169 median for GLP-1 providers.
Effectiveness25%
8.0/10Live Vital offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.3/10Online intake and platform experience — consult included in the price; 7 platform features disclosed.
Trust & Safety15%
8.0/10Key details fully confirmed by our editors; no FDA warning letters on file (last checked 2026-06-16).
Accessibility10%
8.2/10Live Vital treats patients in all 50 states.
Support10%
5.8/10Live Vital provides standard clinician follow-up; no extended coaching or community program is disclosed.
How we verified this Live Vital review
Last checked 2026-06-16- Confirmed current pricing across 2 dose/plan tiers
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: high.
GLP-1 medications Live Vital offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| Compounded Semaglutide | compounded | $99 |
| Compounded Tirzepatide | compounded | $183 |
What we like
- Physician-led — founded by Dr. Patrick Taylor, MD; all treatments doctor-prescribed via the clinical team
- Transparent published pricing: semaglutide from $99/mo, tirzepatide from $183/mo (billed as 3-month programs)
- Every plan includes doctor prescribing, licensed-pharmacy medication, and direct-to-door shipping
- Unlimited messaging with the care team; cancel or pause anytime with no lock-in
- Fully telehealth in all 50 states
Watch-outs
- Sold as 3-month programs (semaglutide $299 / tirzepatide $549 per quarter); 'starting at' rates can rise with dose
- Doesn't accept insurance (HSA/FSA funds only)
- Compounding pharmacy isn't named (only 'a licensed US pharmacy')
- Also a peptide/longevity practice; those peptides are not FDA-approved (the site discloses this)
Is Live Vital worth it? Our verdict
Live Vital positions itself around one thing: shoppers who want low-cost, physician-led compounded GLP-1 with peptide and hormone options. It runs $99/month — toward the affordable end of the market. It treats patients in all 50 states, so access isn't a barrier.
How much Live Vital actually costs
- Compounded semaglutide — $99/month
- Compounded tirzepatide — $183/month
That puts Live Vital below the roughly $169 median ongoing price across the GLP-1 providers we track — a real cost advantage.
Medications: what Live Vital prescribes
Live Vital prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products — the standard trade-off across the compounded-GLP-1 market.
Who Live Vital is best for — and who should skip it
A good fit if you…
- are focused on the lowest ongoing monthly cost.
- live anywhere in the US and want guaranteed access.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
Live Vital treats patients in all 50 states. We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
Live Vital earns its place on the shortlist mainly on price: at $99/month it's one of the more affordable ways to stay on a GLP-1, without obvious corners cut on access or oversight.
Ready to start with Live Vital?
Starting at $99/month. See current pricing and start your free consultation.
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Live Vital review:
Sources & methodology — as of June 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Alternatives to Live Vital
Editorial score · methodology
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with Live Vital?
Starting at $99/month. See current pricing and start your free consultation.